Methotrexate, used for the treatment of RA, inhibits the K48-linked polyubiquitination of Numb and promotes Notch-1 ubiquitination, thus restricting the expression of Notch-1 (145). The gene discussed is NOTCH1; the disease is rheumatoid arthritis.